<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08800049000922</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>Kairax SUB Q</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130020</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:14:10.832Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000915</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>Kairax DEEP</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130019</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:14:09.693Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000908</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>Kairax FINE</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130018</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:14:08.425Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000892</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>Nexfill Volume</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130087</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:14:07.222Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000885</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>Nexfill Deep</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130086</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:14:01.226Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000878</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>Nexfill Fine</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130085</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:14:00.015Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000823</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>AESSOA ULTRA</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130073</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:58.816Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000816</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>AESSOA GLOBAL</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130071</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:57.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000809</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>AESSOA DEEP</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130072</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:51.612Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000793</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>AESSOA SHINE</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130070</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:50.416Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000786</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>LUXFILL PLUS SUB-Q</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130007</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:49.214Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000779</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>LUXFILL PLUS DEEP</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130008</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:48.021Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000762</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>LUXFILL PLUS FINE</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130009</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:42.008Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000038</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>QTFILL PLUS AQ</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130114</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:40.823Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000021</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>QTFILL PLUS FINE</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130013</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:39.608Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000014</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>QTFILL PLUS DEEP</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130012</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:38.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800049000007</udiDi>
    <basicUdiDi>88000490QTFPRH</basicUdiDi>
    <tradeName>QTFILL PLUS Sub-Q</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid injectable gel with Lidocaine / QTFILL PLUS</deviceName>
    <manufacturerName>S.THEPHARM Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000020813</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>130011</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:13:32.417Z</lastUpdated>
  </row>
</eudamedExport>